Xhibit Corp. (XBTC) [Rocket]

Overview

Xhibit Corp. (XBTC)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
09/02/2015	8-K	Quarterly results
07/30/2015	8-K	Other Events, Financial Statements and Exhibits
04/07/2015	8-K	Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi...
02/10/2015	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/23/2015	8-K	Bankruptcy or Receivership, Regulation FD Disclosure, Financial Statements and Exhibits
01/16/2015	8-K	Regulation FD Disclosure
12/16/2014	8-K	Termination of a Material Definitive Agreement

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-13	Dec-31-12	Dec-31-11	Dec-31-10	Sep-19-10	Dec-31-09	Dec-31-08	Sep-19-01
Revenues	74.4	9.8	6.4	0.0	0.0	0.0	0.0	0.0
Revenue growth	661.5%	53.9%
Cost of goods sold	44.9	4.7	3.8	0.0	0.2	0.0	0.0	0.1
Gross profit	29.5	5.1	2.6	0.0	-0.2	0.0	0.0	-0.1
Gross margin	39.7%	52.0%	40.8%
Selling, general and administrative					0.0	0.0	0.0	0.1
Sales and marketing	12.7	1.1	0.4		0.0	0.0	0.0
Research and development	1.3	0.6	0.0
General and administrative	12.8	3.8	2.5	0.0	0.0	0.0	0.0
EBITA	-30.3	-0.2	-0.3	0.0	-0.2	0.0	0.0	-0.1
EBITA margin	-40.7%	-1.9%	-5.2%
Amortization of intangibles	2.4	0.2
EBIT	-32.7	-0.3	-0.3	0.0	-0.2	0.0	0.0	-0.1
EBIT margin	-44.0%	-3.5%	-5.2%
Pre-tax income	-173.9	-0.4	-0.3	0.0	-0.2	0.0	0.0	-0.1
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Earnings from continuing ops	-172.6	-0.4	-0.3	0.0	-0.2	0.0	0.0	-0.1
Earnings from discontinued ops	-1.3
Net income	-173.9	-0.4	-0.3	0.0	-0.2	0.0	0.0	-0.1
Net margin	-233.6%	-4.0%	-5.3%

Diluted EPS	($1.84)	($0.01)	($0.01)	($0.02)		($0.02)	($0.03)
Shares outstanding (diluted)	93.8	67.0	63.6	1.4		1.4	1.3

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.